Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Rapid Responses to:
|
|
Rapid Responses published:
|
|
|||
|
Sujoy Maitra, SpR General Medicine & Gastroenterology RVI, Newcastle; NE1 4LP
Send response to journal:
|
Dr Brady highlights the importance of routine troponin, CT scan and Echocardiogram to identify the patients who are more likely to have adverse outcome from a Pulmonary Embolism (PE). At present CT Scan is used as a tool for diagnosing PE in patients who have established lung disease or in whom Ventilation/Perfusion(V/Q) Scan is inconclusive but there is a good clinical suspicion of PE .Apart from that how would it change our practice if we start using CT Scan, troponin or Echocardiogram routinely,simply to stratify risk,in patients where a diagnosis of PE has already been established? Even if all these tests show evidence of RV strain or increased risk of adverse outcome, I believe, we would still continue to treat them with Low molecular weight heparin,with or without an initial bolus of intravenous unfractionated heparin(depending on local practice),as we do at the moment.And obviously we would thrombolyse them if there is significant haemodynamic instability. So as far as I understand doing all these investigations is more of research interest than something which would substantially change the way we treat Pulmonary Embolism at present. Competing interests: None declared |
|||